Efficacy and Safety of the Novel Oral Anticoagulants Compared to Warfarin in Patients with Non Valvular Atrial Fibrillation

Ilaria Gagliardi, Teresa Bruni, Elisa Rauseo,Vincenzo Paravati,Francesco Barilla,Concetta Torromeo,Giuseppe Pannarale,Cesare Greco,Michele Schiariti,Carlo Gaudio

Journal of the American College of Cardiology（2016）

引用 0|浏览7

暂无评分

摘要

The prophylactic treatment of thromboembolism is a key step in managing of patients with atrial fibrillation. Novel oral anticoagulants (NOAC) have been developed as alternatives to warfarin in Non Valvular Atrial Fibrillation (NVAF). The aim of this study was to compare NOAC, both as first

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要